Dark

CRNX
Crinetics Pharmaceuticals, Inc.
stock NASDAQ

At Close

Jul 6, 2026 3:59:58 PM EDT

42.01USD-0.509%(-0.22)4,856,294

42.01Bid 48.60Ask 6.59Spread

Pre-market

Jul 6, 2026 9:25:30 AM EDT

42.30USD+0.166%(+0.07)498

After-hours

Jul 6, 2026 4:59:48 PM EDT

83.93USD+99.762%(+41.92)1,769,198

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.43B

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Aug 4, 2026 (29d)

CRNX Stats

Avg. Vol. 10 Day

1,716,457

Avg. Vol. 30 Day

1,201,886

Employees

210

Market Cap

4,432,179,143

Shares Out.

105,440,208

On/Off Exchange

58%/42%

6 Month Beta

0.89

1 Year Beta

1.01

2 Year Beta

1.13

3 Year Beta

1.15

52 Week Low

25.83

52 Week High

57.99

SMA50

36.79

SMA200

41.84

1 Week

+13.79%

1 Month

+27.69%

3 Month

+11.50%

6 Month

-8.52%

1 Year

+44.65%

2 Year

-4.10%

5 Year

+101.61%

Profile

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.

CRNX Stock Summary

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) stock price today is $42.01, and today's volume is 4,856,294. CRNX is down -0.509% today. The 30 day average volume is 1,201,886. CRNX market cap is 4.43B with 105,440,208 shares outstanding.

.dark-mode .qHJ07p{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .qHJ07p{ color: #333333; background-color: white; border: 2px solid #333333; }CRNXCrinetics Pharmaceuticals, Inc.stock NASDAQ

CRNX Stock Summary

CRNX
Crinetics Pharmaceuticals, Inc.
stock NASDAQ